Literature DB >> 5444311

Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon.

S G Romeo, R E Whalen, J P Tindall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5444311     DOI： 10.1001/archinte.125.5.825

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  6 in total

1.  Effect of low dose intra-arterial reserpine on vascular wall norepinephrine content.

Authors:  J M Porter; C G Reiney
Journal:  Ann Surg       Date:  1975-07       Impact factor: 12.969

2.  Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate.

Authors:  B Cortet; R M Flipo; P Coquerelle; B Duquesnoy; B Delcambre
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

3.  Prostaglandin E1 therapy for digital ulcers in scleroderma.

Authors:  M Baron; G Skrinskas; M B Urowitz; P N Madras
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

4.  Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.

Authors:  K H Nilsen; M I Jayson
Journal:  Br Med J       Date:  1980-06-14

5.  Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.

Authors:  K D Nolph; L Miller; F C Husted; P Hirszel
Journal:  Int Urol Nephrol       Date:  1976       Impact factor: 2.370

6.  Reserpine treatment of Raynaud's disease.

Authors:  B A Nobin; S L Nielsen; B Eklov; N A Lassen
Journal:  Ann Surg       Date:  1978-01       Impact factor: 12.969
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.